Table 3 Effect of TXA treatment (100 mg/ml) on chondrocyte cell cycle distribution (%)
From: Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes
Moments | ||||||
|---|---|---|---|---|---|---|
Untreated | 10′/0 h | 10′/24 h | 10′/48 h | 24 h | 48 h | |
Cell cycle phase | ||||||
G0/G1 | 92.35 ± 1.31 | 92.36 ± 1.15 | 87.71 ± 1.01 | 89.61 ± 2.82 | 84.61 ± 2.6 | 83.93 ± 2.2 |
S | 3.06 ± 0.79 | 1.94 ± 0.58 | 7.50 ± 0.84 | 2.66 ± 0.66 | 5.93 ± 1.02 | 6.58 ± 1.17 |
G2/M | 4.59 ± 0.99 | 5.71 ± 0.62 | 4.79 ± 1.04 | 7.73 ± 2.18 | 9.45 ± 1.68 | 9.38 ± 1.57 |